US does not approve AstraZeneca for chronic nasal disease
![](https://4gi.tv/wp-content/uploads/2022/03/1503-ws-he-1024x576.png)
AstraZeneca said the US regulator has refused to approve the asthma drug Fasenra for the treatment of chronic rhinosinusitis with nasal polyps, a condition characterized by benign growths that cause pain and congestion.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/07/2607-02.png)
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env2.jpg)
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env.jpg)
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM